Evidence map›Paper›PMID 32305063›Full record

ArticleBMC neurology2020

Aneurysmal subarachnoid haemorrhage: effect of CRHR1 genotype on fatigue and depression.

Artur Vetkas, Ele Prans, Sulev Kõks, Tõnu Rätsep, Toomas Asser

Open access · goldAbstract read
In one paragraph

Article in BMC neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Artur VetkasTartu University Hospital, Tartu, Estonia. Artur.Vetkas@gmail.com.
Ele PransTartu University, Tartu, Estonia.
Sulev KõksCentre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia.
Tõnu RätsepTartu University Hospital, Tartu, Estonia.
Toomas AsserTartu University Hospital, Tartu, Estonia.
University of Tartu · EEMurdoch University · AUTartu University Hospital · EE

Funding

Eesti Teadusagentuur IUT20-46Eesti Teadusagentuur IUT2-4
6 · The paper itself

Abstract

backgroundEmotional health disturbances are common after aneurysmal subarachnoid hemorrhage (aSAH) and their causes are largely unexplored. Corticotropin-releasing hormone receptor 1 (CRHR1) is a key factor in stress reactivity and development of mental health disturbances after adverse life-events.

methodsWe explore the effect of CRHR1 genotype on mental health after aSAH in a retrospective cohort study. One hundred twenty-five patients have been assessed using EST-Q mental health questionnaire. Genotyping of CRHR1 single nucleotide polymorphisms (SNP-s) was performed (Rs7209436, Rs110402, Rs242924).

resultsFatigue was present in almost half of aSAH patients, depression and anxiety in one-third. There was a high prevalence of insomnia and panic complaints. Rs110402 minor allele decreased the risk of depression (OR = 0.25, p = 0.027 for homozygotes). Depression was present in 14% vs 41% in minor and major allele homozygotes, respectively. Rs110402, Rs242924 and Rs7209436 minor alleles and TAT-haplotype, formed by them, were protective against fatigue. After Bonferroni correction only the association of Rs110402 with fatigue remained statistically significant (OR = 0.21, p = 0.006 for minor allele homozygotes). Results remained statistically significant when adjusted for gender, admission state, age and time from aSAH. In multiple regression analysis occurrence of fatigue was dependent on anxiety, modified Rankin score and Rs110402 genotype (R

conclusionsCRHR1 minor genotype was associated with a lower risk of fatigue and depression after aSAH. Genetic predisposition to mental health disturbances associated with negative life-events could be a risk factor for fatigue and depression after aSAH and selected patients might benefit from advanced counselling in the recovery phase.

Indexed as

DepressionFatigueSubarachnoid HemorrhageCRF Receptor, Type 1Genetic Predisposition to DiseaseGenotypeHumansPolymorphism, Single NucleotideReceptors, Corticotropin-Releasing HormoneRetrospective StudiesRisk FactorsCRF Receptor, Type 1Receptors, Corticotropin-Releasing HormoneAneurysmCortitrophin-releasing hormone receptor-type 1CRHR1DepressionFatigueGeneMental healthSNPSubarachnoid haemorrhage

Identifiers

PMID32305063
PMCPMC7165373
OpenAlexW3016378876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.